Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2017

Conditions
Blunt Thoracic Aortic Injury
Interventions
DEVICE

Valiant Thoracic Stent Graft with the Captivia Delivery System

All subjects will be implanted with this device

Trial Locations (25)

22908

University Of Virginia, Charlottesville

23507

Sentara Norfolk General Vascular & Transplant Specialists, Norfolk

27710

Duke University Medical Center, Durham

32608

University of Florida Shands Hospital, Gainesville

33136

University of Miami Jackson Memorial, Miami

33709

Bayfront Medical Center, St. Petersburg

35294

University of Alabama, Birmingham

43606

Toledo Hospital / Jobst Vascular Center, Toledo

48073

William Beaumont Hospital, Royal Oak

48109

University of Michigan, Ann Arbor

53226

Medical College of Wisconsin Froedtert Hospital, Milwaukee

75390

UT Southwestern, Dallas

76508

Scott and White Memorial, Temple

77030

Memorial Hermann Heart and Vascular Institute, Houston

78234

Brooke Army Medical Center, San Antonio

80204

Denver Health, Denver

90048

Cedars Sinai Medical Center, Los Angeles

90502

Harbor UCLA, Torrance

06510

Yale New Haven Hospital, New Haven

04105

Maine Medical Center, Portland

02215

Beth Israel Deaconess Medical Center, Boston

08103

Cooper Health, Camden

07960

Vascular Research Institute, Morristown

N6A5W9

London Health Sciences Center, London

QCG1V

Laval Hospital, Québec

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medtronic Cardiovascular

INDUSTRY

NCT01092767 - Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury | Biotech Hunter | Biotech Hunter